Cerus CORP Form 4 insider transactions

Daniel N. Swisher JR, a Director at Cerus Corporation, has been granted 60,000 Restricted Stock Units (RSUs) as part of the company's 2024 Equity Incentive Plan.

CERUS Corporation Director Jami K. Nachtsheim was granted 60,000 Restricted Stock Units (RSUs) on June 3, 2025, increasing her total beneficial ownership to 208,362 shares.

CERUS Corporation's Director, Ann Lucena, was granted 60,000 Restricted Stock Units (RSUs) as part of the company's 2024 Equity Incentive Plan, aligning her interests with shareholder value.

CERUS Corp. Director Shan Hua reported the acquisition of 60,000 Restricted Stock Units (RSUs) on June 3, 2025, increasing her total beneficial ownership to 132,386 shares.

Cerus Corp. Director Eric Bjerkholt was granted 60,000 Restricted Stock Units (RSUs) on June 3, 2025, increasing his beneficial ownership to 222,133 shares.

Chrystal Jensen, Chief Legal Officer of Cerus Corp, sold shares on March 13 and 14, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Cerus Corporation's Chief Operating Officer, Vivek K. Jayaraman, sold shares of common stock on March 13 and 14, 2025, to cover statutory tax withholding obligations related to vesting restricted stock units.

Cerus Corporation's CEO, William Greenman, sold shares on March 13 and 14, 2025, to cover statutory tax withholding obligations related to vesting restricted stock units.

Kevin Green, CFO of Cerus Corporation, sold shares of common stock on March 13 and 14, 2025, to cover statutory tax withholding obligations related to vesting restricted stock units.

Chief Medical Officer Richard J. Benjamin sold shares of Cerus Corp stock on March 13 and 14, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Chrystal Jensen, Chief Legal Officer of Cerus Corporation, reports the acquisition and disposal of common stock and restricted stock units (RSUs).

Chief Operating Officer Vivek K. Jayaraman of Cerus Corporation reports acquisition and disposal of common stock and restricted stock units (RSUs).

Cerus Corporation's CEO, William Greenman, reports acquisition and disposal of common stock and restricted stock units (RSUs).

Kevin Green, CFO of Cerus Corporation, reports acquisition and disposal of common stock and restricted stock units (RSUs) in recent transactions.

Chief Medical Officer Richard J. Benjamin reports acquisition and disposal of Cerus Corp stock, including grants of restricted stock units (RSUs) and sales to cover tax obligations.

Chrystal Jensen, Chief Legal Officer of Cerus Corporation, reports the acquisition and disposal of common stock and restricted stock units.

Chief Operating Officer Vivek K. Jayaraman of Cerus Corporation reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

William Greenman, President and CEO of Cerus Corporation, reports the acquisition of shares through restricted stock units and the sale of shares to cover tax obligations.

Kevin Green, CFO of Cerus Corporation, reports the acquisition and disposal of common stock and restricted stock units.

Chief Medical Officer Richard J. Benjamin of Cerus Corp reports the sale of common stock to cover tax obligations and pursuant to a 10b5-1 trading plan.

Chrystal Jensen, Chief Legal Officer of Cerus Corporation, reports acquiring 13,912 restricted stock units on February 26, 2025, according to a Form 4 filing with the SEC.

Cerus Corporation's Chief Operating Officer, Vivek K. Jayaraman, reported the acquisition of 23,850 restricted stock units on February 26, 2025, according to a Form 4 filing with the SEC.

William Greenman, CEO of Cerus Corporation, reports acquiring 57,637 restricted stock units on February 26, 2025, according to a Form 4 filing with the SEC.

Cerus Corporation's Chief Financial Officer, Kevin Green, reports the acquisition of 18,550 restricted stock units (RSUs) following the satisfaction of performance criteria.

Richard J. Benjamin, Chief Medical Officer of Cerus Corporation, reports acquiring 13,912 restricted stock units on February 26, 2025, according to a Form 4 filing.

Cerus Corp director Dean A. Gregory purchased 1,725 shares of common stock at a price of $1.70 per share on December 13, 2024.

A Cerus Corp director, Eric Bjerkholt, sold 20,000 shares of common stock at an average price of $1.785 per share on December 12, 2024.

Cerus Corporation's Chief Legal Officer, Chrystal Jensen, sold 16,667 shares of common stock at an average price of $1.71, executed under a pre-arranged 10b5-1 trading plan.

Kevin Green, CFO of Cerus Corporation, sold a total of 82,657 shares of common stock on September 3rd and 4th, 2024, under a pre-arranged 10b5-1 trading plan.

Chrystal Jensen, Chief Legal Officer of Cerus Corporation, sold 16,667 shares of common stock at an average price of $2.065 per share on August 15, 2024, under a pre-arranged 10b5-1 trading plan.